Clinical Bioinformatics and its role in Clinical research

                                 
Clinical Research and Biomakers

 Scientific Federation invites all the participants from all over the world to attend 2nd World Congress on Clinical Research & Biomarkers during September 17-18, 2018 Toronto, Canada. 
Computational learning is the discovery of new knowledge about health and disease. In Bioinformatics methods in clinical research experts examine the latest developments in the area of cancer, AIDS, HIV, HBV etc., this research helps for clinical diagnosis, prognosis and there is the peptic purpose. It also helps in selecting the appropriate tool to analyze the data obtained from the technique for clinical research validation.  Bioinformatics nowadays helps in clinical research by developing universal human genome database. In 1998, experiments were conducted on “Expressed Sequence tags” (EST) in human stem cells Bioinformatics. 10,000 sequences were analyzed using these methodologies in genomics, proteomics, metabolomics, drug biomarkers, dermatology and clinical quality care. The sequencing of the database varied and it was identified that few sequences showed already know sequence database. Some showed previously identified with public domino sequence. Others were undescribed. Few also showed mitochondrial DNA, Ribosomal DNA. Thus, applications for bioinformatics are Identification of genomic medicine (EMR’S, PHR’S), Pharmacogenomic Biomarkers (CYP2D6, OATP181, UGTIAI, and TPMT) and Analysis of omitting data. The term “Clinical Bioinformatics” is the “Clinical application of bioinformatics associate sciences and technologies to understand molecular mechanism and potential therapies for human diseases”, a new and important concept for the development of the disease. We are having solid evidence that the generation and expansion of genomic, transcriptomic and proteomic data from human studies by high throughput biotechnologies have increased enormously. In the same way, clinical measurements and examined information are elevated by the development of advanced clinical devices.

Clinical bioinformatics plays an important role in many numbers of clinical applications, metabolic and signaling pathways, biomarker discovery, genomics, proteomics, human tissue bank and profiling, and systems biology. This way we could summarize the high potentialities of Bioinformatics in a various field based on the sequencing information and referring the sequenced database.
Continue Reading

Translational safety biomarkers

WCCRB-2018
Scientific Federation invites all the participants from all over the world to attend 2nd World Congress on Clinical Research &Biomarkers during September 17-18, 2018 Toronto, Canada  which includes Keynote presentations, Oral talks, Poster presentations and Exhibitions.WCCRB-2018 will also provide the excellent opportunity to meet experts, exchange information, and strengthen the collaboration among Directors, Researchers, Associate Professors, and Scholars from both academia and industry.

Translational research is the research process that investigates and translates nonclinical research results into clinical applications and tests their safety and efficacy in a Phase 1 clinical trial. One characteristic of safety biomarkers is that they are noninvasive and translate between species. Biomarkers may have their greatest value in early efficacy and safety evaluations such as in vitro studies in tissue samples, in vivo studies in animal models, and early-phase clinical trials to establish “Proof of Concept.”

Translational safety biomarkers can predict, detect, and monitor drug-induced toxicity during human trials for testing drugs and are needed to assess whether toxicities observed in laboratory animal studies are relevant to humans at therapeutic doses experimental animals, the biomarker also must be one that is relevant to humans. These “Translational Biomarkers” can be rigorously studied in animals, thereby establishing well-defined relationships between biomarker levels and tissue histopathology. There are many animal models and human cohorts that are useful in studying aging, but important limitations include marked differences among them that make translating animal findings to humans difficult, a number of key limitations that affect longitudinal studies in both humans and animals, and the need to study multimorbidity and complexity for translational research to be generalizable to most older adults. There are generally two categories of translational research: Basic to clinical and Clinical to population; however basic to clinical and clinical to population are often used to represent transitions between to patient-oriented, patient oriented to population-based, and basic to population-based research. In third have five categories, which include Basic biomedical research, Clinical translation, Translation to populations, Translation to practice and Demonstrating efficacy.

Results from Basic Biomedical research and Clinical Translation research have impacted numerous policies related to bringing new diagnostics and therapeutics through clinical trials, while findings from Translation Efficacy and Demonstrating efficacy research have been effective in informing policy, especially regarding the models and financing of health care delivery in various populations.


                                  
Continue Reading

Testing Tool for Animals

  
Currently the vast majority of antibodies available for research purpose produced by live animals through procedures that are of great concern from both animal’s welfare and scientific stand point. Millions of animals suffer for prolonged periods of time to produce antibodies used in research.

Two methods are used to produce the two types of antibodies that are most commonly used in research: Monoclonal Antibodies and Polyclonal Antibodies. In the mouse monoclonal as cites methods, once the animals begins making the desired antibody, the mice are killed and their spleens are harvested to isolate the antibodies produced B lymphocyte.

These cells are then fused with cancerous cells to generate a hybridoma which will multiply indefinitely. These hybridomas are injected into the abdominal cavities of mine where they multiply continually.

Achievements:
     Research with cows helped create the world’s first vaccine, which in turn helped end small pox. Studies with monkeys, dogs and mice led to the polio vaccine.

Animal testing is not an alternative to human trials, it complements it. Thus we cannot completely rely on the animal testing and take it for granted that they will surpass the human testing phases as well. To have the discussions about the clinical trials and animal testing please join the forum of Clinical Research and Biomarkers (WCCRB-2018) which is during September 17-18, 2018 at Toronto, Canada.
Continue Reading

Clinical Research & Biomarkers


Scientific Federation invites all the participants from all over the world to attend Global Summit on Clinical Research & Biomarkers during August 21-23, 2017 in Dallas, USA which includes Keynote presentations, Oral talks, Poster presentations and Exhibitions.

GSCRB-2017 will also provide the excellent opportunity to meet experts, exchange information, and strengthen the collaboration among Directors, Researchers, Associate Professors, and Scholars from both academia and industry. The main theme of the conference is "Latest Improvements in Determining the Future of Biomarkers".

The Global Summit on Clinical Research & Biomarkers is anticipating participants from 40 and more countries across the globe and the three day conference will provoke Plenary sessions, Keynote speeches, Poster, and Oral presentations. This program provides three days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.

Our pleasure to meet you in upcoming event…!!! 
Continue Reading
Subscribe to: Posts (Atom)